Patent · US Active

Process for preparing spray dried formulations of 4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethylbenzonitrile

US9603803B2 · kind B2 · utility

0Cited by

2References

9Claims

0Family size

Assignee

Janssen Sciences Ireland UC · IE

Inventors

Filip René Irena Kiekens · Geel, BE
Jody Firmin Marceline Voorspoels · Reningelst, BE
Lieven Elvire Colette Baert · Brugge, BE

Key dates

Filing date	Feb 16, 2012
Grant date	Mar 28, 2017
Priority date	—
Expiry date	Feb 16, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to a process for producing a spray-dried powder comprising microcrystalline cellulose in a solid dispersion of the anti-HIV compound etravirine (TMC125) in a water-soluble polymer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.